• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 4
  3. Author

Online ISSN: 2515-8260

Volume9, Issue4

Surgical outcome assessment in femoral fracture patients with or without teriparatide treatment

    Dr. SAMUDRALA SREENIVAS, Dr. SAINATH REDDY MANDA, Dr. SAMUDRALA VIPANCHI

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 4, Pages 1445-1450

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Introduction: Femoral fracture and atypical subtrochanteric fracture are thought to be uncommon side effects of long-term bisphosphonate treatment. Delay in bone healing may be caused by a decreased rate of bone turnover. Limited research has shown that teriparatide therapy may counteract the effects of bisphosphonates and promote bone repair.
Methods: A retrospective assessment of individuals with atypical subtrochanteric and femoral fractures associated with the use of bisphosphonates were examined. There were 18 female patients signed up. The characteristics of an unusual fracture were congruent with the radiographic findings. All underwent surgical intervention, and teriparatide usage was suggested after surgery. Perioperative results, clinical, and radiographic outcomes were all considered outcome indicators.
Keywords:
    Bisphosphonates femur fractures Osteoporosis subtrachanteric Teriparatide
  • PDF (158 K)
  • XML
(2022). Surgical outcome assessment in femoral fracture patients with or without teriparatide treatment. European Journal of Molecular & Clinical Medicine, 9(4), 1445-1450.
Dr. SAMUDRALA SREENIVAS, Dr. SAINATH REDDY MANDA, Dr. SAMUDRALA VIPANCHI. "Surgical outcome assessment in femoral fracture patients with or without teriparatide treatment". European Journal of Molecular & Clinical Medicine, 9, 4, 2022, 1445-1450.
(2022). 'Surgical outcome assessment in femoral fracture patients with or without teriparatide treatment', European Journal of Molecular & Clinical Medicine, 9(4), pp. 1445-1450.
Surgical outcome assessment in femoral fracture patients with or without teriparatide treatment. European Journal of Molecular & Clinical Medicine, 2022; 9(4): 1445-1450.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 71
  • PDF Download: 98
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus